Drug Approval Package

ALKERAN (Melphallan) Tablets
Company:  Glaxo Wellcome, Inc.
Application No.:  14-691/S20
Approval Date: 5/24/2001

• Approval Letter(s) (PDF)  

• Printed Labeling (PDF)  

• Chemistry Review(s) (PDF)  

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)  

• Administrative Document(s) (PDF)  

• Correspondence (PDF)  

Date created: July 05, 2003

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.